Ann Aine Hanly
2021
In 2021, Ann Aine Hanly earned a total compensation of $4.7M as Chief Technology Officer at Vir Biotechnology.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Non-Equity Incentive Plan | $249,200 |
| Option Awards | $2,367,738 |
| Salary | $338,385 |
| Stock Awards | $1,451,400 |
| Other | $84,635 |
| Total | $4,741,358 |
Hanly received $2.4M in option awards, accounting for 50% of the total pay in 2021.
Hanly also received $250K in bonus, $249.2K in non-equity incentive plan, $338.4K in salary, $1.5M in stock awards and $84.6K in other compensation.
Rankings
In 2021, Ann Aine Hanly's compensation ranked 2,780th out of 12,405 executives tracked by ExecPay. In other words, Hanly earned more than 77.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,780 out of 12,405 | 78th |
Division Manufacturing | 1,100 out of 5,494 | 80th |
Major group Chemicals And Allied Products | 434 out of 2,369 | 82nd |
Industry group Drugs | 378 out of 2,090 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 109 out of 452 | 76th |
Source: SEC filing on April 7, 2022.
Hanly's colleagues
We found four more compensation records of executives who worked with Ann Aine Hanly at Vir Biotechnology in 2021.